Waters (NYSE:WAT) Stock Price Expected to Rise, UBS Group Analyst Says
Waters (NYSE:WAT – Get Free Report) had its price objective hoisted by research analysts at UBS Group from $405.00 to $410.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. UBS Group’s target price suggests a potential upside of 10.90% from the company’s current […]
Waters (NYSE:WAT – Get Free Report) had its price objective hoisted by research analysts at UBS Group from $405.00 to $410.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. UBS Group’s target price suggests a potential upside of 10.90% from the company’s current […]
